Mouse models of arrhythmogenic cardiovascular disease: Challenges and opportunities

Current Opinion in Pharmacology

Volumn 15, Issue 1, 2014, Pages 107-114

  Nerbonne, Jeanne M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARRHYTHMOGENESIS; ARTICLE; CALCIUM CURRENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; HEART MUSCLE POTENTIAL; HUMAN; ION CURRENT; LONG QT SYNDROME 1; LONG QT SYNDROME 2; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; P WAVE; POTASSIUM CURRENT; PRIORITY JOURNAL; QRS COMPLEX; QT PROLONGATION; RISK ASSESSMENT; RISK FACTOR; SODIUM CURRENT; T WAVE; WAVEFORM;

ANIMALS; ARRHYTHMIAS, CARDIAC; DISEASE MODELS, ANIMAL; HUMANS; MICE;

EID: 84898901817     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2014.02.003     Document Type: Review

References (46)

1. Chugh SS: Early identification of risk factors for sudden cardiac death. Nat Rev Cardiol 2010, 7:318-326
2. Fishman GI, Chugh S, DiMarco J, Albert C, Anderson M, Bonow RO, Buxton A, Chen PS, Estes M, Jouven X et al.: Sudden cardiac death prediction and prevention. Report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation 2010, 122:2335-2348
3. Brenyo AJ, Huang DT, Aktas MK: Congenital long and short QT syndromes. Cardiology 2012, 122:237-247
4. Faggioni M, Knollmann GC: Calsequestrin 2 and arrhythmias. Am J Physiol Heart Circ Physiol 2012, 302:H1250-H11260
5. 2+ cycling proteins and gene mutations. Wien Med Wochenschr 2012, 162:292-296
6. Venetucci L, Denegri M, Napolitano C, Priori SG: Inherited calcium channelopathies in the pathophysiology of arrhythmias. Nat Rev Cardiol 2012, 9:561-575
7. Abriel H, Zaklyazminskaya EV: Cardiac channelopathies: genetic and molecular mechanisms. Gene 2013, 517:1-11
8. Chandra N, Bastiaenen R, Papadakis M, Sharma S: Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. J Am Coll Cardiol 2013, 61:1027-1040
9. Duygu B, Poels EM, da Costa Martins PA: Genetics and epigenetics of arrhythmia and heart failure. Front Genet 2013, 4 219.013
10. Buxton AE, Ellison KE, Lorvidhaya P, Ziv O: Left ventricular ejection fraction for sudden death risk stratification and guiding implantable cardioverter-defibrillators implantation. CJ Cardiovasc Pharmacol 2010, 55:450-455
11. Adabag AS, Luepker RV, Roger VL, Gersh BJ: Sudden cardiac death: epidemiology and risk factors. Nat Rev Cardiol 2010, 7:216-225
12. Amerena JV, Walters TE, Mirzaee S, Kalman JM: Update on the management of atrial fibrillation. Med J Aust 2013, 199:592-597
13. Munger TM, Wu LQ, Shen WK: Atrial fibrillation. J Biomed Res 2014, 281:1-17
14. El-Atat FA, McFarlane SI, Sowers JR, Bigger JT: Sudden cardiac death in patients with diabetes. Curr Diab Rep 2004, 4:187-193 (Pubitemid 38899148)
15. Zhou L, Deng W, Zhou L, Fang P, He D, Zhang W, Liu K, Hu R: Prevalence, incidence and risk factors of chronic heart failure in the type 2 diabetic population: systematic review. Curr Diabetes Rev 2009, 5:171-184
16. London B: Cardiac arrhythmias: from (transgenic) mice to men. J Cardiovasc Electrophysiol 2001, 12:1089-1092
17. Nerbonne JM, Kass RS: Molecular physiology of cardiac repolarization. Physiol Rev 2005, 85:1205-1253 (Pubitemid 41362269)
18. Ravens U, Cerbai E: Role of potassium currents in cardiac arrhythmias. Europace 2008, 10:1133-1137
19. Charpentier F, Demolombe S, Escande D: Cardiac channelopathies: from men to mice. Ann Med 2004, 36(Suppl. 1):28-34 (Pubitemid 38669921)
20. Nerbonne JM: Studying cardiac arrhythmias in the mouse - a reasonable model for probing mechanisms? Trends Cardiovasc Med 2004, 14:83-93 (Pubitemid 38569674)
21. McCauley MD, Wehrens XHT: Animal models of arrhythmogenic cardiomyopathy. Dis Model Mech 2009, 2:563-570
22. Charpentier F, Bourgé A, Mérot J: Mouse models of SCN5A-related cardiac arrhythmias. Prog Biophys Mol Biol 2008, 98:230-237
23. Huang CL, Lei L, Matthews GD, Zhang Y, Lei M: Pathophysiological mechanisms of sino-atrial dysfunction and ventricular conduction disease associated with Scn5a deficiency: insights from mouse models. Front Physiol 2012, 3:234
24. Bader PL, Faizi M, Kim LH, Owen SF, Tadross MR, Alfa RW, Bett GC, Tsien RW, Rasmusson RL, Shamloo M: Mouse model of Timothy syndrome recapitulates triad of autistic traits. Proc Natl Acad Sci U S A 2011, 108:15432-15437
25. Bett GC, Lis A, Wersinger SR, Baizer JS, Duffey ME, Rasmusson RL: A mouse model of timothy syndrome: a complex autistic disorder resulting from a point mutation in Cav1.2. N Am J Med Sci 2012, 5:135-140
26. Drum BM, Dixon RE, Yuan C, Cheng EP, Santana LF: Cellular mechanisms of ventricular arrhythmias in a mouse model of Timothy syndrome (long QT syndrome 8). J Mol Cell Cardiol 2014, 66:63-71
27. Nuyens D, Stengl M, Dugarmaa S, Rossenbacker T, Compernolle V, Rudy Y, Smits JF, Flameng W, Clancy CE, Moons L et al.: Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat Med 2001, 7:1021-1027 (Pubitemid 32937382)
28. Fabritz L, Kirchhof P, Franz MR, Nuyens D, Rossenbacker T, Ottenhof A, Haverkamp W, Breithardt G, Carmeliet E, Carmeliet P: Effect of pacing and mexiletine on dispersion of repolarization and arrhythmias in DeltaKPQ SCN5A (long QT3) mice. Cardiovasc Res 2003, 57:1085-1093 (Pubitemid 36324614)
29. Leoni AL, Gavillet B, Rougier JS, Marionneau C, Probst V, LeScouamec S, Schott JJ, Demolombe S, Bruneval P, Huang CL et al.: Variable Na(v)1.5 protein expression from the wild-type allele correlates with the penetrance of cardiac conduction disease in the Scn5a+/S mouse model. PloS One 2010, 5:e9298
30. Kalume F, Westenbroek RE, Cheah CS, Yu FH, Oakley JC, Scheuer T, Catterall WA: Sudden unexpected death in a mouse model of Dravet syndrome. J Clin Invest 2013, 123:1798-1808
31. Lopez-Santiago LF, Meadows LS, Ernst SJ, Chen C, Malhotra JD, McEwen DP, Speelman A, Noebels JL, Maier SK, Lopatin AN, Isom LL: Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. J Mol Cell Cardiol 2007, 43:636-647 (Pubitemid 47615043)
32. to,f. FASEB J 2008, 22:3648-3660
33. Gutstein DE, Morley GE, Tamaddon H, Vaidya D, Schneider MD, Chen J, Chien KR, Stuhlmann H, Fishman GI: Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 2001, 88:333- 339 (Pubitemid 32173758)
34. Lu?bkemeier I, Requardt RP, Lin X, Sasse P, Andrié R, Schrickel JW, Chkourko H, Bukauskas FF, Kim JS, Frank M et al.: Deletion of the last five C-terminal amino acid residues of connexin43 leads to lethal ventricular arrhythmias in mice without affecting coupling via gap junction channels. Basic Res Cardiol 2013, 108:348-364.
35. Kuo HC, Cheng CF, Clark RB, Lin JJ, Lin JL, Hoshijima M, Nguyêñ-Trân VT, Gu Y, Ikeda Y, Chu PH et al.: A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell 2001, 107:801-813 (Pubitemid 34033672)
36. + channel interacting protein 2 (KChIP2) is required for the generation of native myocardial fast transient outward currents. J Physiol 2013, 591:4149-4166.
37. Liu N, Colombi B, Memmi M, Zissimopoulos S, Rizzi N, Negri S, Imbriani M, Napolitano C, Lai FA, Priori SG: Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. Circ Res 2006, 99:292-298 (Pubitemid 44174937)
38. 2+ handling and causes complex ventricular arrhythmias in mice. Cardiovasc Res 2007, 75:69-78 (Pubitemid 46873510)
39. Liu N, Denegri M, Dun W, Boncompagni S, Lodola F, Protasi F, Napolitano C, Boyden PA, Priori SG: Abnormal propagation of calcium waves and ultrastructural remodeling in recessive catecholaminergic polymorphic ventricular tachycardia. Circ Res 2013, 113:142-152
40. + currents with left ventricular hypertrophy. Circ Res 2008, 102:1406-1415
41. Bignolais O, Quang KL, Naud P, El Harchi A, Briec F, Piron J, Bourge A, Leoni AL, Charpentier F, Demolombe S: Early ion-channel remodeling and arrhythmias precede hypertrophy in a mouse model of complete atrioventricular block. J Mol Cell Cardiol 2011, 51:713-721
42. Yang K-C, Jay PY, McMullen JR, Nerbonne JM: Enhanced cardiac P13Ka signaling mitigates arrhythmogenic electrical remodeling in pathological cardiac hypertrophy and heart failure. Cardiovasc Res 2012, 93:252-262
43. Lehnart SE: Understanding the physiology of heart failure through cellular and in vivo models-towards targeting of complex mechanisms. Exp Physiol 2013, 98.3:622-628
44. Rentschler S, Harris BS, Kuznekoff L, Jain R, Manderfield L, Lu MM, Morley GE, Patel VV, Epstein JA: Notch signaling regulates murine atrioventricular conduction and the formation of accessory pathways. J Clin Invest 2011, 121:525-533
45. Rentschler S, Yen AH, Lu J, Petrenko MS, Lu MM, Manderfield LJ, Patel VV, Fishman GI, Epstein JA: Myocardial notch signaling reprograms cardiomyocytes to a conduction-like phenotype. Circulation 2012, 126:1058-1066
46. Pallante BA, Giovannone S, Fang-Yu L, Zhang J, Liu N, Kang G, Dun W, Boyden PA, Fishman GI: Contactin-2 expression in the cardiac Purkinje fiber network. Circ Arrhythm Electrophysiol 2010, 3:186-194